Coco Kou
Directeur Financier/CFO chez QHY GROUP
Postes actifs de Coco Kou
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| QHY GROUP | Directeur Financier/CFO | - | - |
| Comptroller/Controller/Auditor | - | - | |
| FOUR LEAF ACQUISITION CORPORATION | Directeur Financier/CFO | 01/01/2022 | - |
Historique de carrière de Coco Kou
Anciens postes connus de Coco Kou
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Directeur Financier/CFO | 01/01/2019 | 01/01/2021 |
Formation de Coco Kou
| Peking University | Graduate Degree |
| Columbia Business School | Masters Business Admin |
| London Business School | Masters Business Admin |
| University of Hong Kong | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Chine | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Director of Finance/CFO | 3 |
| Masters Business Admin | 3 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Consumer Services | 5 |
| Industrial Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| QHY GROUP | Industrial Services |
| FOUR LEAF ACQUISITION CORPORATION | Finance |
| Entreprise privées | 1 |
|---|---|
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
